• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Andrei Gonzales Discusses Struggles of Move to Value-Based Care

Video

As the healthcare system adjusts to the transition to value-based care, providers in particular are having a hard time keeping up with all of the changes, said Andrei Gonzales, director of value-based reimbursement initiatives at McKesson Health Solutions.

As the healthcare system adjusts to the transition to value-based care, providers in particular are having a hard time keeping up with all of the changes, said Andrei Gonzales, director of value-based reimbursement initiatives at McKesson Health Solutions.

Transcript (slightly modified)

What remains the biggest hurdle facing the US in the move to value-based care?

I’d say the biggest hurdle is the transition from the current fee-for-service structure, to a value-based reimbursement structure. The study that we did shows that providers are struggling, and they are lagging payers in their progression towards value-based reimbursement.

And you know, providers have a very busy job right now just to take care of their patients, and the transition requires a lot of work in terms of building care coordination capabilities, in terms of building data integration so that all the different stakeholders in the continuum of care really understand what’s happening for their patients in these value-based models and understand where opportunities for improvement are, and to be able to make those changes to really see the improvements that they’re looking for. So that transition is going to be a very heavy lift; it has been and it’s going to continue to be until we reach more of a steady state and gone through this transition phase.

Related Videos
Mei Wei, MD.
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Sandra Cueller, PharmD
Ticiana Leal, MD
James Chambers, PhD
Mabel Mardones, MD.
Dr Bonnie Qin
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
© 2024 MJH Life Sciences
AJMC®
All rights reserved.